A working group formed by the European Group for Blood and Marrow Transplantation (EBMT) and European LeukemiaNet has developed recommendations for prophylaxis and treatment of acute and chronic GVHD. The four-part recommendations cover prevention of GVHD in standard myeloablative transplantation, prevention of GVHD in reduced-intensity transplantation, treatment of acute GVHD, and treatment of chronic GVHD. The group's report recommends that the guidelines be adopted as standards in transplant centers and used as a standard of care in studies evaluating the advantages and disadvantages of practices differing from the recommendations.
Report: Prophylaxis and Treatment of GVHD
Aug 2013